CUSIP 71722W107COMPHATQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
172 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 12.47M | $206.82M | 0 | Held |
| 2 | Medicxi Ventures Management (Jersey) Ltd | 7.46M | $123.84M | 0 | Held |
| 3 | Invesco Ltd. | 3.92M | $65.04M | +55.5K | Added |
| 4 | Blackrock, Inc. | 3.56M | $58.99M |
| +153.2K |
| Added |
| 5 | Carlyle Group Inc. | 3.50M | $57.98M | 0 | Held |
| 6 | Vanguard Group Inc | 3.18M | $52.71M | −38.4K | Reduced |
| 7 | Ensign Peak Advisors, Inc | 2.35M | $39.02M | −151.3K | Reduced |
| 8 | Millennium Management LLC | 2.08M | $34.54M | −3.00M | Reduced |
| 9 | Nea Management Company, LLC | 1.96M | $32.52M | 0 | Held |
| 10 | 683 Capital Management, LLC | 1.78M | $29.61M | −35.4K | Reduced |
See every fund holding Phathom Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders